US Open — Novak Djokovic not the only one to have officials derail a championship run – ESPN

Sep 6, 2020

Jeremy WillisESPN.com

On Sunday, Novak Djokovic, the top-ranked men's player at the US Open, was defaulted from his fourth-round match after hitting a ball that struck a line judge.

The match's umpire and officials conferred and ruled to default Djokovic, essentially ejecting him from the tournament. The United States Tennis Association said that it's justified by the rule book, "in accordance with the Grand Slam rulebook, following his actions of intentionally hitting a ball dangerously or recklessly within the court or hitting a ball with negligent disregard of the consequences."

Despite what seemed like no malicious intent, Djokovic is out, leaving a tournament already missing Roger Federer and Rafael Nadal, wide open. There are two other fairly recent examples of similar rulings in tennis events, according to the Associated Press. In 2017, Denis Shapovalov was defaulted from a Davis Cup match when he accidentally hit the chair umpire in the face with a ball. At Wimbledon in 1995, Tim Henman hit a ball into the head of a ball girl and was defaulted from a doubles match.

While some offenses are worse than others, and it doesn't happen often in championship events, breaking the rules is breaking the rules and a player is ousted by officials. Sometimes, it affects the results of the game.

1 Related

Here are some other occasions when refs and rule-breaking changed a championship.

1968 Masters: It appeared Roberto De Vicenzo would meet Bob Goalby in an 18-hole playoff after finishing tied at the 1968 Masters. However, De Vicenzo's playing partner marked an incorrect, one-stroke-higher score for a hole. De Vicenzo did not catch the error and signed his scorecard. The rule states a golfer has to take the higher score. Goalby won the Masters, his only major title, by that one-stroke mistake.

1985 World Series, Game 7: The St. Louis Cardinals' Joaquin Andujar was the last player to be ejected from a World Series while actively playing in the game. Andujar was ejected by plate umpire Don Denkinger, one pitch after Cards manager Whitey Herzog was ejected for arguing balls and strikes. Andujar charged Denkinger and bumped him before being restrained by teammates. The game was out of hand, with the Kansas City Royals up big, when both Herzog and Andujar were ejected, so this was more frustration and didn't affect the final results.

2006 World Cup: In extra time, France's Zinedine Zidane, after being provoked by Italy's Marco Materazzi, head-butted Materazzi. Zidane received a red card and was sent off. Zidane was one of the French team's top scorers, and he wasn't available when the match went to penalty kicks. Italy would win 5-3 in penalty kicks.

2009 US Open Women's semifinal: In the match against Kim Clijsters, Serena Williams was assessed a foot fault penalty. Then Williams subsequently argued the call and was given a point penalty. Without a point to give, Williams lost the match, and Clijsters would win the US Open.

2010 World Cup final: In the first period of extra time (109th minute), John Heitinga of the Netherlands received his second yellow card of the match for a slide tackle on Spain's Andres Iniesta, calling for an ejection. Iniesta would go on to score the match-deciding goal just seven minutes later, giving Spain its first World Cup title.

2011 Stanley Cup Final, Game 3: The game had been in action for just over five minutes when Vancouver Canucks defenseman Aaron Rome checked Nathan Horton of the Boston Bruins in the head after he had already dished the puck, sending Horton crashing to the ice. Horton was taken off the ice on a stretcher and diagnosed with a concussion. In addition to being penalized and ejected, Rome was suspended for the remaining four games of the series. Following Rome's ejection, the Canucks were outscored 21-4 the rest of the series, which Boston won 4-3.

2013 Federated Auto Parts 400: This was the final race leading into the Chase for the Sprint Cup. Three teams (Michael Waltrip Racing, Penske Racing and Front Row Motorsports) had attempted to manipulate the finish of the race as well as Chase positions. As a result, Michael Waltrip Racing was fined $300,000, the largest fine a team had received in NASCAR history. Additionally, Clint Bowyer and Martin Truex Jr. were docked 50 driver points, removing them from wild-card position.

2016 NBA Finals, Game 4: Golden State Warriors forward Draymond Green had already racked up three flagrant fouls in the playoffs. Toward the end of Game 4 against the Cleveland Cavaliers, Green became angry with LeBron James, who stepped over Green while he was on the floor. Green swung his arm and appeared to make contact with James' groin. The following day, Green received his fourth flagrant foul and was suspended for Game 5, becoming the first player to be suspended from the NBA Finals since 2006. Green also was Golden State's top defender, and with him out, James and Cavs point guard Kyrie Irving combined to score 82 points. This allowed Cleveland to pull closer at 3-2 in the series, before winning the title in seven games.

2020 College Football Playoff National Championship game: In a controversial ruling, Clemson linebacker James Skalski was ejected in the third quarter of the title matchup because of a targeting hit on LSU wide receiver Justin Jefferson. Trailing 28-25 at the time, Clemson's offense couldn't help a defense without its second-leading tackler. LSU would score the next 14 points to win 42-25.

Research from ESPN Stats and Information contributed to this story.

More here:

US Open -- Novak Djokovic not the only one to have officials derail a championship run - ESPN

Complementary and Alternative Medicine Market : Global Forecast Over 2024 – Owned

Alternative medicines include treatments other than allopathic. Alternative medicine treatments include systems with healing ability such as acupuncture, acupuncture, naturopathy, herbal remedies, and homeopathy. The medical profession does not regard these healing systems as orthodox treatment systems. Some of these treatments are accepted to be of value for certain conditions. Herbal medicines include drugs that are derived from plants. Herbal medicines are either used for therapeutic purpose, or as supplements to improve well-being or health. Herbal products are available as teas, extracts, powders, capsules, tablets, and others. These products are natural, hence considered to be safe. Herbal medicines have the ability to cure almost all the types of diseases.

Request a Sample of Complementary and Alternative Medicine Market: https://www.transparencymarketresearch.com/checkout.php?rep_id=39398&ltype=S

Nutraceutical is a combination of the words nutrition and pharmaceutical. Nutraceutical medicines or products are fortified food or food products that provide supplementary diet and also help in prevention and treatment of diseases except anemia. Nutraceuticals are not regulated and tested to the extent of pharmaceutical drugs. These have the ability to treat diseases including ADHD, amyotrophic lateral sclerosis, anemia, sickle cell, anxiety, aphthous ulcer, carnitine deficiency, depression, dietary supplementation, dyspareunia, eye conditions, fibromyalgia, herbal supplementation, herpes simplex, herpes simplex, suppression, high cholesterol, Huntingtons disease, hypertriglyceridemia, insomnia, jet lag, muscle pain, nonalcoholic fatty liver disease, osteoarthritis, Parkinsons disease, peripheral neuropathy, premenstrual dysphoric disorder, rheumatoid arthritis, short bowel syndrome, and smoking cessation.

Request a PDF Brochure https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=39398

Probiotics are live yeasts and bacteria that benefit the health of individuals. These are referred as healthy, helpful, or good bacteria. An imbalance of natural yeasts or bacteria within the body has been associated with a range of indications including suppressed immune system, yeast infections, skin rashes, weight gain, diarrhea, and constipation. Probiotics may be taken orally to restore any imbalance in the normal urogenital or intestinal flora. These are available as contained naturally, or dietary supplements or added to foods such as kefir, sauerkraut, or yogurt. Increase in inclination toward safe and lesser side effects boosts the global alternative medicines market. Rise in side effects and adverse drug reactions due to usage of allopathic medicines drives the market. Surge in awareness about the benefits relating to alternative medicines is a key driver of the market. However, slow healing ability of alternative medicines restrains the market.

Request for Analysis of COVID19 Impact on Complementary and Alternative Medicine Market https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=39398

The global alternative medicines market can be segmented based on drug class, dosage form, disease indication, distribution channel, and region. In terms of drug class, the market can be categorized into herbal products, nutraceutical products, and probiotics. Based on dosage form, the global alternative medicines market can be classified into tablets, powder, syrup, capsules, teas, extracts, and others. In terms of disease indication, the market can be divided into ADHD, amyotrophic lateral sclerosis, anemia, sickle cell, anxiety, aphthous ulcer, carnitine deficiency, depression, dietary supplementation, dyspareunia, eye conditions, fibromyalgia, herbal supplementation, herpes simplex, herpes simplex, suppression, high cholesterol, Huntingtons disease, hypertriglyceridemia, insomnia, jet lag, muscle pain, nonalcoholic fatty liver disease, osteoarthritis, Parkinsons disease, peripheral neuropathy, premenstrual dysphoric disorder, rheumatoid arthritis, short bowel syndrome, smoking cessation, and others. Based on distribution channel, the global alternative medicines market can be categorized into online pharmacies, retail pharmacies, and hospital pharmacies.

Pre-Book Complementary and Alternative Medicine Market Report https://www.transparencymarketresearch.com/checkout.php?rep_id=39398&ltype=S

Geographically, the global alternative medicines market can be segmented into Latin America, Asia Pacific, Europe, North America, and Middle East & Africa. North America held the largest market share in 2016 due to extensive awareness and acceptance by the large population in the region. Europe held the second largest market share in 2016 owing to increased awareness and sale of alternative medicines in drug stores. The global alternative medicines market in Asia Pacific is projected to grow at a rapid pace during the forecast period from 2017 to 2025. The market in Middle East & Africa and Latin America are expected to witness moderated growth during the forecast period due to rise in demand for food supplements and natural health.

Key players in the global alternative medicines market include Dr. Willmar Schwabe India Pvt. Ltd., GUNA S.p.a., BIORON GmbH, Ainsworth, Inc., Kanak Drishti Infotech Pvt. Ltd., and Random Beauty, Inc.

About Us

Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.

Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through ad hoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.

TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.

Contact

90 State Street, Suite 700Albany, NY 12207Tel: +1-518-618-1030USA Canada Toll Free: 866-552-3453Website:https://www.transparencymarketresearch.com

Read More Reports: https://www.prnewswire.com/news-releases/radiopharmaceutical-market-to-reach-valuation-of-us-5-4-bn-by-2027-transparency-market-research-301018881.html

See the article here:

Complementary and Alternative Medicine Market : Global Forecast Over 2024 - Owned

New England Journal of Medicine Publishes Positive Results from Phase 2 WILLOW Study of Brensocatib in Patients with Non-Cystic Fibrosis…

BRIDGEWATER, N.J., Sept. 7, 2020 /PRNewswire/ -- Insmed Incorporated (Nasdaq:INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, today announced that final results from the Phase 2 WILLOW study of brensocatib in patients with non-cystic fibrosis bronchiectasis (NCFBE) were published online in the New England Journal of Medicine (NEJM). New data from subgroup analyses of the WILLOW study also were presented today during a late-breaking clinical trials session at the virtual European Respiratory Society (ERS) International Congress 2020. Brensocatib is a novel, first-in-class, oral, reversible inhibitor of dipeptidyl peptidase 1 (DPP1) being developed by Insmed for the treatment of bronchiectasis and other inflammatory diseases.

"We are very pleased that NEJM has recognized the significance of the Phase 2 WILLOW data for patients with NCFBE. These results demonstrate the potential clinical benefits of directly reducing neutrophil-mediated inflammation in bronchiectasisa critical finding for patients who currently suffer from severe outcomes in the absence of an approved therapy," said Martina Flammer, M.D., MBA, Chief Medical Officer of Insmed. "We eagerly anticipate initiating our Phase 3 program for brensocatib in bronchiectasis later this year as we work to bring this urgently needed solution to patients."

The results published today showed that brensocatib significantly prolonged time to first pulmonary exacerbation, the primary endpoint, over the 24-week treatment period for both treatment doses versus placebo (p=0.03 for the 10 mg group; p=0.04 for the 25 mg group). The risk of exacerbation at any time during the trial was reduced by 42% for the 10 mg group versus placebo (HR 0.58, p=0.03) and by 38% for the 25 mg group versus placebo (HR 0.62, p=0.046).

Treatment with brensocatib also reduced the rate of pulmonary exacerbations, a key secondary endpoint. Patients treated with brensocatib experienced a 36% reduction in the 10 mg arm (p=0.04) and a 25% reduction in the 25 mg arm (p=0.17), compared with the placebo arm. In addition, mean concentrations of active neutrophil elastase (NE) in sputum showed dose-dependent reductions compared with placebo over the 24-week treatment period.

Importantly, study results were consistent among subgroups based on age, baseline NE concentrations, prior exacerbation history, bronchiectasis severity index, and lung function.

"The WILLOW study demonstrated that among patients with NCFBE who have a history of frequent exacerbations, treatment with brensocatib significantly prolonged the time to first exacerbation and reduced the risk of exacerbation over the treatment period. Annualized rates of exacerbation were also lower compared to placebo," said lead author James Chalmers, MBChB, Ph.D., Professor and Consultant Respiratory Physician at the School of Medicine, University of Dundee, UK. "These results are critically important given the lack of approved pharmaceutical therapies to reduce the risk of exacerbationthe major driver of morbidity and mortality in patients with bronchiectasis. The results also validate the novel mechanism of action of brensocatib and highlight the potential benefits of reducing neutrophil serine protease activity."

In addition to the results published in NEJM, new data from the WILLOW study were presented today at the ERS International Congress. Subgroup analyses showed that brensocatib consistently prolonged time to first exacerbation and reduced rates of exacerbation among patient subgroups analyzed by baseline disease severity, P. aeruginosa infection, and sputum NE concentration. Further, brensocatib reduced the sputum concentrations of all three neutrophil serine proteases (NSPs) assessed (NE, proteinase 3, and cathepsin G).

Brensocatib was generally well-tolerated in the WILLOW study. Rates of adverse events (AEs) leading to drug discontinuation in patients treated with placebo, brensocatib 10 mg, and brensocatib 25 mg were 11%, 7%, and 7%, respectively. The most common AEs in patients treated with brensocatib were cough, headache, sputum increase, dyspnea, infective exacerbation of bronchiectasis, and diarrhea.

Rates of adverse events of special interest (AESIs) in patients treated with placebo, brensocatib 10 mg, and brensocatib 25 mg, respectively, were as follows: rates of skin events (including hyperkeratosis) were 12%, 15%, and 24%; rates of dental events were 4%, 16%, and 10%; and rates of infections considered AESIs were 18%, 14%, and 17%. Hyperkeratosis was reported in 1/85, 3/81, and 1/89 patients treated with placebo, brensocatib 10 mg, and brensocatib 25 mg, respectively. The study included extensive dental evaluations to closely monitor progression of periodontal disease. The results did not raise a signal about dental safety. The percentage of patients with change in periodontal pocket depth 2 mm and absolute value of 5 mm (the threshold of concern for periodontal disease) were 12%, 11%, and 12% for placebo, brensocatib 10 mg, and brensocatib 25 mg, respectively. No skin or dental adverse events were considered serious.

Brensocatib received breakthrough therapy designation from the U.S. Food and Drug Administration in June 2020 for the treatment of adult patients with NCFBE for reducing exacerbations. Insmed plans to initiate a Phase 3 program for brensocatib in bronchiectasis by the end of 2020.

About WILLOW

WILLOW was a randomized, double-blind, placebo-controlled, parallel-group, multi-center, multi-national, Phase 2 study to assess the efficacy, safety and tolerability, and pharmacokinetics of brensocatib administered once daily for 24 weeks in patients with non-cystic fibrosis bronchiectasis (NCFBE). WILLOW was conducted at 116 sites and enrolled 256 adult patients diagnosed with NCFBE who had at least two documented pulmonary exacerbations in the 12 months prior to screening. Patients were randomized 1:1:1 to receive either 10 mg or 25 mg of brensocatib or matching placebo. The primary efficacy endpoint was the time to first pulmonary exacerbation over the 24-week treatment period in the brensocatib arms compared to the placebo arm.

About Brensocatib

Brensocatib is a small molecule, oral, reversible inhibitor of dipeptidyl peptidase I (DPP1) being developed by Insmed for the treatment of patients with bronchiectasis. DPP1 is an enzyme responsible for activating neutrophil serine proteases (NSPs), such as neutrophil elastase, in neutrophils when they are formed in the bone marrow. Neutrophils are the most common type of white blood cell and play an essential role in pathogen destruction and inflammatory mediation. In chronic inflammatory lung diseases, neutrophils accumulate in the airways and result in excessive active NSPs that cause lung destruction and inflammation. Brensocatib may decrease the damaging effects of inflammatory diseases such as bronchiectasis by inhibiting DPP1 and its activation of NSPs.

About Non-Cystic Fibrosis Bronchiectasis

Non-cystic fibrosis bronchiectasis (NCFBE) is a severe, chronic pulmonary disorder in which the bronchi become permanently dilated due to a cycle of infection, inflammation, and lung tissue damage. The condition is marked by frequent pulmonary exacerbations requiring antibiotic therapy and/or hospitalizations. Symptoms include chronic cough, excessive sputum production, shortness of breath, and repeated respiratory infections, which can worsen the underlying condition. NCFBE affects approximately 340,000 to 520,000 patients in the U.S. Today, there are no approved therapies specifically targeting NCFBE in the U.S., Europe, or Japan.

About Insmed

Insmed Incorporated is a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases. Insmed's first commercial product, ARIKAYCE (amikacin liposome inhalation suspension), is the first and only therapy approved in the United States for the treatment of refractory Mycobacterium avium complex (MAC) lung disease as part of a combination antibacterial drug regimen for adult patients with limited or no alternative treatment options. MAC lung disease is a chronic, debilitating condition that can cause severe and permanent lung damage. Insmed is also advancing brensocatib, a novel oral reversible inhibitor of dipeptidyl peptidase 1 with therapeutic potential in bronchiectasis and other inflammatory diseases, and treprostinil palmitil, an inhaled formulation of a treprostinil prodrug that may offer a differentiated product profile for rare pulmonary disorders, including pulmonary arterial hypertension. For more information, visit http://www.insmed.com.

Forward-looking Statements

This press release contains forward-looking statements that involve substantial risks and uncertainties. "Forward-looking statements," as that term is defined in the Private Securities Litigation Reform Act of 1995, are statements that are not historical facts and involve a number of risks and uncertainties. Words herein such as "may," "will," "should," "could," "would," "expects," "plans," "anticipates," "believes," "estimates," "projects," "predicts," "intends," "potential," "continues," and similar expressions (as well as other words or expressions referencing future events, conditions or circumstances) may identify forward-looking statements.

The forward-looking statements in this press release are based upon the Company's current expectations and beliefs, and involve known and unknown risks, uncertainties and other factors, which may cause the Company's actual results, performance and achievements and the timing of certain events to differ materially from the results, performance, achievements or timing discussed, projected, anticipated or indicated in any forward-looking statements. Such risks, uncertainties and other factors include, among others, the following: the risk that brensocatib does not prove effective or safe for patients in future clinical studies, including the STOP-COVID19 study; business or economic disruptions due to catastrophes or other events, including natural disasters or public health crises; impact of the novel coronavirus (COVID-19) pandemic and efforts to reduce its spread on our business, employees, including key personnel, patients, partners and suppliers; failure to successfully commercialize or maintain U.S. approval for ARIKAYCE, the Company's only approved product; uncertainties in the degree of market acceptance of ARIKAYCE by physicians, patients, third-party payors and others in the healthcare community; the Company's inability to obtain full approval of ARIKAYCE from the FDA, including the risk that the Company will not timely and successfully complete the study to validate a PRO tool and complete the confirmatory post-marketing study required for full approval of ARIKAYCE; inability of the Company, PARI or the Company's other third party manufacturers to comply with regulatory requirements related to ARIKAYCE or the Lamira Nebulizer System; the Company's inability to obtain adequate reimbursement from government or third-party payors for ARIKAYCE or acceptable prices for ARIKAYCE; development of unexpected safety or efficacy concerns related to ARIKAYCE or brensocatib; inaccuracies in the Company's estimates of the size of the potential markets for ARIKAYCE or brensocatib or in data the Company has used to identify physicians; expected rates of patient uptake, duration of expected treatment, or expected patient adherence or discontinuation rates; the Company's inability to create an effective direct sales and marketing infrastructure or to partner with third parties that offer such an infrastructure for distribution of ARIKAYCE; failure to obtain regulatory approval to expand ARIKAYCE's indication to a broader patient population; failure to successfully conduct future clinical trials for ARIKAYCE, brensocatib and the Company's other product candidates, including due to the Company's limited experience in conducting preclinical development activities and clinical trials necessary for regulatory approval and the Company's inability to enroll or retain sufficient patients to conduct and complete the trials or generate data necessary for regulatory approval; risks that the Company's clinical studies will be delayed or that serious side effects will be identified during drug development; failure to obtain, or delays in obtaining, regulatory approvals for ARIKAYCE outside the U.S. or for the Company's product candidates in the U.S., Europe, Japan or other markets, including the United Kingdom as a result of its recent exit from the European Union; failure of third parties on which the Company is dependent to manufacture sufficient quantities of ARIKAYCE or the Company's product candidates for commercial or clinical needs, to conduct the Company's clinical trials, or to comply with laws and regulations that impact the Company's business or agreements with the Company; the Company's inability to attract and retain key personnel or to effectively manage the Company's growth; the Company's inability to adapt to its highly competitive and changing environment; the Company's inability to adequately protect its intellectual property rights or prevent disclosure of its trade secrets and other proprietary information and costs associated with litigation or other proceedings related to such matters; restrictions or other obligations imposed on the Company by its agreements related to ARIKAYCE or the Company's product candidates, including its license agreements with PARI and AstraZeneca AB, and failure of the Company to comply with its obligations under such agreements; the cost and potential reputational damage resulting from litigation to which the Company is or may become a party, including product liability claims; the Company's limited experience operating internationally; changes in laws and regulations applicable to the Company's business, including any pricing reform, and failure to comply with such laws and regulations; inability to repay the Company's existing indebtedness and uncertainties with respect to the Company's ability to access future capital; and delays in the execution of plans to build out an additional FDA-approved third-party manufacturing facility and unexpected expenses associated with those plans.

The Company may not actually achieve the results, plans, intentions or expectations indicated by the Company's forward-looking statements because, by their nature, forward-looking statements involve risks and uncertainties because they relate to events and depend on circumstances that may or may not occur in the future. For additional information about the risks and uncertainties that may affect the Company's business, please see the factors discussed in Item 1A, "Risk Factors," in the Company's Annual Report on Form 10-K for the year ended December 31, 2019, our Quarterly Report on Form 10-Q for the quarter ended March 31, 2020 and any subsequent Company filings with the SEC.

The Company cautions readers not to place undue reliance on any such forward-looking statements, which speak only as of the date of this press release. The Company disclaims any obligation, except as specifically required by law and the rules of the SEC, to publicly update or revise any such statements to reflect any change in expectations or in events, conditions or circumstances on which any such statements may be based, or that may affect the likelihood that actual results will differ from those set forth in the forward-looking statements.

Contact:

Investors:

Argot PartnersLaura Perry or Heather Savelle(212) 600-1902Insmed@argotpartners.com

Media:

Mandy FaheySenior Director, Corporate CommunicationsInsmed(732) 718-3621amanda.fahey@insmed.com

View original content to download multimedia:http://www.prnewswire.com/news-releases/new-england-journal-of-medicine-publishes-positive-results-from-phase-2-willow-study-of-brensocatib-in-patients-with-non-cystic-fibrosis-bronchiectasis-301124508.html

SOURCE Insmed Incorporated

Company Codes: NASDAQ-NMS:INSM

Excerpt from:

New England Journal of Medicine Publishes Positive Results from Phase 2 WILLOW Study of Brensocatib in Patients with Non-Cystic Fibrosis...

‘Were not your slaves’: Alternative health providers bristle at warning letters about their coronavirus treatments – USA TODAY

The Bill and Melinda Gates Foundation have invested $350 million to fund treatment and vaccine research to fight coronavirus. USA TODAY

Operation Quack Hack, the federal governments initiative to clamp down on fake coronavirus medications and cures, has exposed a health underground in America brimming with distrust not only of mainstream medicinebut the government itself.

Its a Tea Party for COVID-times.

Its members are angry at government warning letters that many perceive as an infringement on their right to free speech, free trade and people's control over their health care and some are ready to fight back.

A common refrain: How can we trust the same government that signed off onopioids?

The most radical believe that wealthy globalists including Bill Gates and Anthony Fauci created the coronavirus, unleashed it from Wuhan, China, along with immune-system-weakening 5G wireless technology; and intend to install digital ID chips in our bodies at the same time they give us the vaccine.

For them, the two agencies behind Operation Quack Hack the Food and Drug Administration and the Federal Trade Commission are sinister organizations. Their objective is to force everyone to take the vaccine, and the only way to do that is to convince ustheres no other choice.

Were not your slaves, were not in your cult, right-wing talk show host Alex Jones shouted in June at an anti-mask rally in Austin. If you want war, you'd better believe you got war.

Info Wars founder Alex Jones joins nearly 150 anti-mask protesters.(Photo: RICARDO B. BRAZZIELL/AMERICAN-STATESMAN)

False claims: Fact check: 'Plandemic' sequel makes false claims about Bill Gates

COVID-5G: https://www.mcgill.ca/oss/article/covid-19-pseudoscience-technology/how-distrust-and-coinc

Jones got in trouble with the FDA in April for peddling a line of silver products, including silver-laced toothpaste, as a COVID-19 cure.

The majority of alternative health providers that received warning letters are less extreme, but many still think the FDA and FTC are out to get them. The goal as they see it? To protect Big Pharma from competition as their market share grows.

The healthcare system in this country is rigged against inexpensive, safe, and effective natural remedies in favor of expensive pharmaceutical drugs, saidClark Hansen, anaturopathic medical doctor in Arizona,in an email message to USA TODAY. "The US medical system is ignoring any treatment that is not patentable and therefore cannot provide a multi-billion profit for some giant healthcare company.

The FTC warned Hansenin May to stop implying that a combination of elderberry, echinacea and the herb andrographis could prevent coronavirus infection.

In an email to USA TODAY, the FDA said its goalactually isto protect consumers from scammers and products that harm them. The agency added that it doesnt want consumers wasting their time on remedies that may lead to delays in getting proper diagnosis and medical care for COVID-19 and other potentially serious diseases and conditions.

Its sister agency was more succinct.

The FTC has taken aggressive action against marketers who want to take advantage of the anxiety caused by the current health crisis, the agency said in an email.We have done so to prevent consumer injury.There is no other motivation.

Under the law, supplement suppliers are not allowed to use some words "cure," "treat," "prevent," "mitigate" or "diagnose" in promotional materials.

Though many providers openly declare their products wont cure COVID-19, the mention of treat or prevent in the same sentence as "coronavirus" has been enough to trigger a letter from the FTC and FDA.

Recognizing the power of these agencies, mostof the more than 300 companies and individuals that got warning letters have responded by removing or changingmarketing materials on their websites, then they've quietly gotten back to the business of addressing customer ailments.

Theres plenty of money to be made in the herbal remedies and alternative health care market even without a pandemic. Revenueis expected to reach nearly $18 billion in the United States this year, according to IBISWorld, a global economic research firm.

Nevertheless, frustration lies just beneath the surface.

Kate Tietje, who runs the Modern Alternative Mama website and ran afoul of the government for touting Elderberry Elixir, vitamin C and vitamin D as remedies for the coronavirus, had this to say about government regulators in a post she later removed from her website:

Seeing that the FDA allows approved drugs to harm and even kill millions of people, while badgering natural companies that have fewer than 10 reports of unproven adverse effect claims, shows us definitively that its not about keeping people healthy.

Since the onset of the pandemic seven months ago, the FDA and the FTC have sent out an average of 13letters a weekwarning companies and individualsto stop making false claims about their ability to prevent or cure COVID-19.

Many of the recipients have a history of fraud and malfeasance.

They include televangelist JimBakker, who spent five years in prison for defrauding his own ministry back in the 1980s;Gordon Pedersen, who wears a lab coat and stethoscope and calls himself a doctor even though he holds no medical degree; and Matthew Martinez, who agreed to give up his chiropractor'slicense in 2016 after being accused of having sex with clients and suggesting that a patient with multiple sclerosis could be cured by drinking breast milk.

Both Bakker and Pedersen told their followers that Silver Solution was the antidote to COVID-19 and were sued by the government for failing to address allegedly false claims outlined in warning letters.

If the government does not receive an adequate response to its warning letter it can file suit, seek arestraining order to shutdown the company's web sites and operations, commandit to recall and destroy its products and raw materials and refund its customers.

Pedersen refused to participate in court proceedings and could not be reached for comment. Bakker battled back, claiming religious exemption. Court documents filed on his behalf state that his product is a sacrament, as important to his ministry as solicitingdonations and preaching the second coming of Christ.

As for Martinez, the FTC faulted him for claiming that high doses of vitamin C "havea significant impacton treating coronavirus" and that stem cells helpin the healing process.After receiving his warning letter from the FTC, he also boasted that the ultraviolet light in his companys octagon-shaped Blue Room provided virus-killing benefits.

Another warning letter recipient with a history of breaking the law was Richard Marschall. A naturopathic physician, he got busted twice between 2011 and 2017 for introducing misbranded drugs into interstate commerce and spent 60 days in jail. That didnt stop him from marketing a product called the dynamic duo that he said could crush 30 different viral infections including those in the Corona family.

On Aug. 5, Marschall was indicted for the third time on the same charge: introducing misbranded drugs into interstate commerce.

An insistence to keep selling supposed coronavirus cures after being told not to is also what got Marc White Eagle Travalino in trouble.

A self-proclaimed medicine man and shaman who runs website and folksy trading post in Fort Davis, Texas, Travalino got nabbed by the FDA for saying his Kolon Kleen, Maska Miakoda and Shar Mar products were proven to work and destroy the coronavirus. Instead of ceasing his marketing activities after receiving his warning letter, he tried to sell more treatments this time to an undercover agent.

The government responded by shutting down all Travalinos operations, both online and brick-and-mortar.

Some coronavirus treatments exposed by Operation Quack Hack were more outlandish.

Face Vital LLC swore by a battery-powered silicon brush used for cleaning facial pores. Mypurmist argued that its hand-held steam machine was the answer. BioElectric Shield offered a golf-ball-sized pendant to block immune-system-sapping 5G electromagnetic waves.

5G appears to be the straw that broke the camels back when it comes to the spread of the Coronavirus, the company said on its website.An extremely intense rollout of 5G was launched initially in Wuhan City, China.

Is it a coincidence that this is also where the coronavirus outbreak started? the company asked. "We are urging you to get protection from EMF radiation."

At least four makers of electric pulse machines, used by chiropractors to reduce muscle tension, stated online that their devices boost the immune system. Electric pulse therapy is like a power up for your cells akin to giving your cells a cup of coffee to energize and speed up their job, said BioBalance, a Maryland-based company.

Three morecompanies suggested sound waves or music could defeat the virus. Musical Medicine, headed by Dr. Suzanne Jonas, advertised new music "designed to boost your immune system. Spooky2 Scalar, a New York company headed by Matt Forrest, said its new sounds would protect you and your family, andBioenergy Wellness in Miami said it had found a COVID-attacking frequency and that sound frequencies were better at penetrating cells than chemicals.

These treatments and others subject to the warning letters have no ability to help anyone with COVID-19, said professor Arthur Caplan, who heads the medical ethics division at the NYU School of Medicine.

Arthur L. Caplan Ph.D. of New York University's Langone Medical Center.(Photo: John Abbott Photography)

Theyre just emptying our pockets for their own gain and greed, he said.

Caplan added that if companies receiving warning letters had any real virus fighting abilities, Dr. Fauci,director of the National Institute of Allergy and Infectious Diseases, would be talking about them on TV.

If Im going to bet on the future, Caplan said. Im still betting on the infectious disease guys over the vitamin purveyors to work our way out of this,

Peddling potions, balmsand tinctures for ailments asvaried as erectile disfunction and Parkinson's disease, alternative health providers targeted by Operation Quack Hack do most of their business over the Internet.

About four in 10 also operate naturopathic, holistic, acupuncture or chiropractic clinics where practitioners meet with clients to help with pain management or plan healthy alternatives for living on an increasingly toxic planet.

For nearly a third, go-to products for fighting coronavirus virus have been simple the kind of thing any mother might suggest to ward off the flu: vitamin C, vitamin D and zinc. Another 26% offered some mixture of herbs or essential oils that might include elderberries, echinacea, ginger, garlic, licorice, turmeric, peppermint, astragalus root, reishi mushrooms, blackseed oil, olive leaf, dandelion.

In a nod to the New Testament, some even recommend frankincense and myrrh.

Corey Basch, associate professor in the Department of Public Health at William Paterson University in Wayne, N.J., said that vitamins, minerals and other micronutrients are a needed element for maintaining health, including immune function.

But its not always clear for whom these supplements will work and under what circumstances.To Basch and others, that alone justifies the government clamping down on those thatmake a definitive statement about the a cure or treatment forCOVID-19.

They need to have competent scientific evidence that something works and no one has that, said Mitchell Katz, spokesman for the FTC.

Alternative health care providers say that doesnt mean they should be silenced. Thats where Dr. David Brownstein, who believes in the basic mission of the FDA and FTC, says the two agencies have gone too far.

Dr. David Brownstein, of West Bloomfield MI, a AARM member.(Photo: Steven M. Herppich)

A medical doctor who got interested in holistic medicine nearly 30 years ago when his father was suffering from heart disease, Brownstein said he found a new way of looking at health care less centered on medications than on treatments that support the immune system.

Brownstein said one of his patients gave him a book on nutrition, which led him to wean his father off nitroglycerin pills in favor of natural supplements. Within 30 days, he said, his fathers cholesterol fell from 300 to 200, his 20-year history of angina endedand his skin turned from pasty gray to pink.

That led Brownstein to seek out natural therapies for his patients, including an anti-viral strategy that he regularly turns to during flu season. The regimen involves high doses of vitamins A, C, D and iodine for four days, followed, if necessary, by nebulizer treatments of hydrogen peroxide and iodine, then intravenous treatments of hydrogen peroxide, vitamin C and ozone.

Brownstein said he used the same regimen every year for more than 20 yearsand on more than 100 COVID-19 patients during the outbreak in the Detroit suburbs in March and April.

Dr. Brownstein administering viral treatment to patients in April.(Photo: Courtesy)

My partners, nurses and I were going out to see patients in their cars in the parking lot in 30-degree weather in March, Brownstein said. We were giving them IVs in their cars, and as soon as we started treating them they got better. We saw 107 patients. Only one was hospitalized. No one died and no one had to be ventilated.

Instead of drawing praise, Brownstein said he got in trouble with the FTC for posting the results of his 107-person study on his website and including YouTube testimonials from patients who recovered. Brownstein said the FTC faulted his study because it wasnt randomized, meaning he had no untreated control group.

I just couldnt sleep at night if I did that, he said. How could I not have people receive a therapy that I thought could help them?

Dr. Brownstein administering to patients during the onset of the pandemic in April.(Photo: Courtesy)

Brownsteins study was peer-reviewed by three medical doctors and an academicand contained more than 90 citations to scholarly articles and texts. But the FTC still made him pull it off his website. The cost of doing that, he said, is that the general public and fellow doctors around the world didnt get the benefit of what he saw on the front lines of the crisis.

It sends a chill out that you cant report anything about COVID thats positive, Brownstein said. You cant report anything that doesnt fit the narrative that all you can do is wear a mask, social-distance and wait for a vaccine.

The pushback against the governments orders is that they represent an unnecessary overstep against alternative health companies that are doing no harmand may even be providing peace of mind at a difficult time.

Rosalee De la Foret, a best-selling author and herbalist, acknowledged that regulators had a legal right to cite her for mentioning the forbidden word "prevent" in promotional materials about herbal products. But she believes the FDA and FTC are too heavy-handed in applying the law.

Best selling author and herbalist Rosalee De la Foret(Photo: Courtesy)

De la Foret, who mentioned the benefits of an herb called astragalus in one of her articles, maintained that she was very careful to point out that the root was not a cure forCOVID-19 or anything else.

I was trying to be open and honest, De la Foret said. But they were saying that I was wink wink implying that the product could be used to cure the virus.

That interpretation, De la Foret said, prevents people from discussing remedies that might be useful.

Heaven forbid that something in nature might be more effective than a drug, agreedHansen, the Arizona naturopathic doctor.

Ralph Fucetola, a retired lawyer and co-trustee of the Natural Solutions Foundation, also echoed that sentiment.

This Deep State attack on good medicine is particularly outrageous because during a declared pandemic it is ethical, according to the (World Health Organization), to use even unapproved remedies that may offer help, Fucetola said in an article posted in April on OpenSourceTruth.com, a website that pushesback against the mass media. Once again, the Federal authorities are putting themselves squarely against common sense in order to maintain the fiction that the government is here to help.

Ralph Fucetola(Photo: Courtesy)

Fucetola told USA TODAY that theres a distinction between treatment ofa disease, which drug companies provide, and therapies that may benefit a patient, which alternative health companies offer.

Theyre trying to subject us to the treatment of disease standard, Fucetola said. People in the health freedom world, in the natural remedies world, are not trying to treat diseases, were trying to help people achieve a healthy status.

Fucetola said he still hopes to reach an understanding with the FDA and FTC regarding what can be said about Nano Silver, a nutrient he says supports a healthy immune system.

Like most other alternative health providers, he has taken down all allegedly offending documents from his website.Even Jones, the founder of Info Wars, has taken steps to comply.

But some letter recipients, including televangelist JimBakker, silver solution salesman Gordon Pederson non-religious church founder Mark Grenon,and investigative journalist Maryam Henein, are defiant.

Investigative journalist Maryam Henein, who edited the movie "Vanishing of the bees."(Photo: Courtesy)

Henein, who directed the filmVanishing of the Beesand foundedHoneyColony.com, a natural-remedies website, said she drew a warning letter by suggesting that the best coronavirus treatment is prevention and recommending that customers take chelated silver, vitamin C and magnesium.

I know in my heart I did not do anything wrong Henein told USA TODAY. The FDA and FTC are using the coronavirus to attack natural remedies. Theres a reason we call them the medical mafia.

So far, the FDA and FTC have ignored Henein because she made required changes to her website, but they went after Pedersen and Grenon when bothmen refused to play by the rules.

Sued in late April and accused of tryingto defraud consumers by claiming his liquid silver product will destroy all forms of viruses, Pedersen declined to accept any mail from the U.S. attorneys office andchose to represent himself as a sovereign citizen.

He declared that the court had no jurisdiction over him as a private living, flesh and blood man.

U.S.attorneys swiftly responded by persuading the court to impose a restraining order and then shut down Pedersons websites. That, in turn, persuaded Pedersens partners to push him out of his company and agree to reimburse any customers who believed they had been defrauded.

Grenon, who declined to talk to USA TODAY, deployed similar tactics, refusing to recognize the authority of the U.S. government over Genesis II Church of Health and Healing, which offered church members Miracle Mineral Solution a bleach-like substance as a sacrament, in return for donations.

Mark Grenon(Photo: YouTube)

He went further, too, threatening the government and the judge presiding over his case.

In July, law enforcement officials raided his familys headquarters and distribution facility in Bradenton, Florida. They arrested two of his sons, Jonathan and Jordan, who are still being held without bail. They seized cash and goldfrom the company safeand carted off all the companys computers, electronic equipment, files and documents. They also confiscated all raw materials used to make MMS.

Grenon, who was at his familys compound in Colombia at the time of the raid, said in a Youtube video interview with Henein that hes determined to face his accusers. He's certain he will prevail.

Experts say his legal position is not enviable. Its not a good idea to get in a fight with the FDA and the FTC, they say, no matter how righteous you think your cause.

Theyre like the IRS, said Caplan, the NYU medical ethics professor. Flout them, challenge them, dont cooperate and they come down hard.

Read or Share this story: https://www.usatoday.com/story/news/investigations/2020/09/03/government-coronavirus-crackdown-angers-alternative-health-providers/5660997002/

Original post:

'Were not your slaves': Alternative health providers bristle at warning letters about their coronavirus treatments - USA TODAY

How the Germans Invented the Invention – The Berlin Spectator

The Germans have invented so much, their complete series of inventions would create a list so long it would have to be invented first. With all of those inventions it is safe to say the Germans invented the invention.

This is not even about the obvious stuff, such as the wall plug or the bratwurst, but even more useful things or characters like the Easter Bunny or the Fahrenheit temperature scale. Mr. T. Scale was a smart fellow. Yes, we were only testing your attention. The inventor was actually Daniel Gabriel Fahrenheit. All of these conversions. Its all his fault.

Homeopathy and Aspirin

How about the universal medication called Aspirin? It helps people get through colds, it keeps fever down and decreases pain. When given shortly after death, it decreases the risk of a heart attack. Aspirin probably works against everything. It might even cure a terrible taste in music.

Samuel Hahnemann from the town of Meissen developed alternative medicine by coming up with Homeopathy. Hahnemann lived from 1755 to 1843 and tested his plant-based medication on himself. By the way: There is a Hahnemann statue in Washington D.C., not so far from Dupont Circle.

Aloysius Alzheimer, another German, discovered What did he discover again? Yes, we know Alzheimer and dementia are usually not funny at all. It is tough for those affected and their families and friends.

Merkel Cells and Cocaine

Walter Bruch invented a so-called color encoding system for analogue television called PAL. Yes, my TV set uses PAL, pal. It became the European format, while most of America uses a system called NTSC. What in the hell is the difference? No clue.

Germany even invented Merkel Cells, seriously. Those are oval-shaped mechanoreceptors essential for light touch sensation and found in the skin of vertebrates, according to Wiki. Sure. Friedrich Sigmund Merkel is the inventor. And no, he is not related, as far as we know.

Related Articles (This piece continues below.)

Cocaine is another useful German invention. Thats what Pablo Escobar, George Jung and many others must have thought while weighing their Dollar bills, but not those who were exploited, threatened or even killed for or by that stuff. Friedrich Gaedcke first isolated cocaine alkaloid in 1855. Shortly after, it was used for medication.

Diesel Scandal and Marxism

Konrad Zuse, a Berliner by birth, invented the first programmable computer, the Z3. It became operational in May 1941, during WW II. The Nazis supported Zuses work. Because of Nazi Germanys terror, the news about the first computer hardly spread at the time.

The list of German inventions is much longer than this. It includes the Frankfurter sausage, the rocket, Marxism, the Geiger Counter, the Teddy Bear, the Settlers of Catan board game, the Diesel engine, Diesel fuel and the Diesel Scandal. Thanks, Rudolf Diesel. The Germans invented the car, obviously, the motorcycle and something called health insurance.

The MPEG Audio Layer III was invented by Germanys Fraunhofer Institute in 1989. The problem was that nobody needed that compression format back then. A few years later, things looked better. The entire world knows and uses MPEG Audio Layer III, a.k.a. mp3, today.

Porsche 911 and Morphine

Decades before, in 1928, the German-American inventor Fritz Pfleumer introduced paper tape with oxide power. It was the first step towards magnetic tape that was used for audio recordings a lot. Nazi Germany developed the Magnetophon recorder for that purpose. The Allies grabbed two of those machines in Luxemburg during the war.

Robert Bunsen invented the Bunsen Burner we all know from our chemistry classes. His colleagues Ernst Ruska and Max Knoll came up with the electron microscope. The contact lens is a German invention too. Everything is, it seems.

Oh yes, the anti-tank missile, morphine, the Porsche 911, the printing press, adhesive tape, the hole puncher, recyclable paper and radioactive toothpaste (seriously) are German inventions as well. And oxygen. What people breathed before Carl Wilhelm Scheele discovered it in the 18th century is a mystery.

By the way:Thank you for readingThe Berlin Spectator. You can keep on doing so for free, since we do not have any paywalls and we do not intend to introduce any. Thats fine. We are glad you are here.On the other hand, if you likeThe Berlin Spectator, and if you want to support us,you can do so by clickinghere(direct Paypal link). Because of your support, we will worry less. Thank you!

View original post here:

How the Germans Invented the Invention - The Berlin Spectator

Obituary: Orville Pung, who advocated for humane incarceration and drug treatment, served as corrections commissioner to three governors -…

In the late 1980s, when a national crack-cocaine epidemic inspired get-tough-on-crime political movements left and right, Orville Pung had other ideas.

Among them: acupuncture. Pung, a cigar-chomping straight talker who served as the Minnesota Commissioner of Corrections from 1982 to 1993, told the Pioneer Press he believed alternative medicine could help crack addicts beat their addiction, an effort aimed at treating the whole prisoner rather than merely locking them up.

Those and other strategies designed to rethink incarceration as a purely punitive tool resonated on both sides of the political aisle, especially when his approaches were proven to save taxpayers money.When Republican Gov. Arne Carlson was elected to office in 1990, he asked Pung who had served DFL Gov. Rudy Perpich and Republican Gov. Al Quie before him to stay on.

That wouldnt happen today, because of politics, said longtime friend Dan Cain. Orv was the best thing that ever happened to Minnesota corrections.

Pung, a restorative justice advocate and high-ranking corrections official to three governors, died Monday surrounded by family at the Lakeview Hospital in Stillwater. He had suffered a stroke complicated by Parkinsons disease and dementia, a week shy of his 84th birthday.

Pung is survived by his wife Nadine, four children, 10 grandchildren and eight great-grandchildren.

His son Rick Pung recalled how he insisted against installing a modern bathroom in his cabin in northern Wisconsin because, in his view, using an outhouse installed fortitude in the grand-kids.

The one thing my dad instilled in us was how he saw people, no matter who they were, said his daugher, Ann Pung-Terwedo. He always looked for the good in people and always encouraged helping them to move forward in education. And he instilled with us the value of family and hard work.

Pung became an assistant Department of Corrections Commissioner in the mid-1970s, during a tumultuous era for the nations prison system, which had seen riots, scandals and upheaval.

He started as a teacher in 1958 at a state training institution for boys, and by 1974 was superintendent of the facility, located in Red Wing.

As the top corrections official in the 1980s and 1990s, Pung advocated for Sentence to Serve alternatives to incarceration, which offered convicts the chance to work road crews or put out sandbags in advance of floods.

He believed in second chances, said Cain, who retired as director of the RS Eden sober housing, drug rehab and prisoner re-entry program in February. He instilled that in the people who worked for him.

Pung relieved state prison overcrowding by using abandoned state hospitals to hold minimum-security prisoners. He also resisted double-bunking prisoners, or putting more than one prisoner in a single cell.

Not all of his stances went over well in St. Paul. In 1990, Pung supported efforts by a nonprofit to study the feasibility of acquiring a motel at University and Prior avenues and convert it into a minimum-security facility for non-violent criminals, most likely women. The position put him at odds with neighborhood advocates.

By the end of the century, he was openly critical of key aspects of the so-called War on Drugs.

Largely due to enforcement and judicial response to drugs, particularly crack cocaine, a black man is now 19 times more likely than a white man to go to a Minnesota prison, wrote Pung, in a corrections retrospective published in 1999.

By consciously deciding to imprison three times as many citizens as we did two decades ago, have we made things proportionately better? he wrote. Are we safer?

Richard Mulcrone, a former probation officer who once served as chairman of the first full-time paroling authority in Minnesota, worked for Pung for years in state corrections.

He said Pung would welcome some of the present-day debate over the purpose of jail, prisons and corrections, including the increased public scrutiny.

Pung felt we shouldnt consider it an invasion of our privacy, we should consider it an opportunity to tell our story, Mulcrone said. He was a good teacher.

Throughout his 35 years in the states corrections system, Pung advocated for more spending on education and victim services, including battered womens programs, in the hopes of cutting off crime before it escalates.

Pung noted in his 1999 article how even territorial prisons that opened prior to Minnesotas statehood offered the inmates enrollment in night school.

The job that any prison has got to face is to make somebody less dangerous than when they came in, and theres no role for that like education, said Pung, quoted in the Pioneer Press in 2016.

Funeral arrangements will be conducted by Simonet Funeral Home in Stillwater and St. Michaels Church in Stillwater.

Follow this link:

Obituary: Orville Pung, who advocated for humane incarceration and drug treatment, served as corrections commissioner to three governors -...

Demand for Medical Wellness Market to Witness Rapid Surge During the Period 2017 2025 – StartupNG

Wellness describes itself as complete physical mental and social well-being. It comprises all the components used to lead a healthy life. Wellness is multidirectional and constitutes social, emotional, physical, spiritual, intellectual and emotional wellbeing. According to National Wellness Institute, two more component of wellness includes cultural and environmental wellness. Mental health and well-being are an integral and essential component of health. Wellness goes further than disease or disability and highlights the maintenance and improvement of health and well-being of the person. Wellness includes activities that improve health, enhance the quality of life and increase the levels of well-being of the person. Different types of wellness include workplace wellness, wellness tourism, lifestyle wellness and others. In order to help prevent disease, reduce stress, and enhance the overall quality of life Global Wellness Institute (GWI) organizes e Global Spa & Wellness Summit (GSWS) annually, that brings together leaders and visionaries to discuss various aspects of health and wellbeing.

For more insights into the Market, request a sample of this report @ https://www.persistencemarketresearch.com/samples/18787

Nowadays, people are focusing on preventive, proactive aspects of wellness, wellness economy incorporates industrial sector that enables consumers to incorporate wellness into their lives. Consumers are inclining towards preventive measures to prevent diseases and maintain good health. The key sector of wellness includes wellness tourism, fitness, complementary & alternative medicine, lifestyle wellness, rejuvenation and spa industry, workplace wellness and others.

Wellness is self-responsibility and is opening new opportunities for wellness market as due to increase in geriatric population, rise in disease population due to sedentary lifestyle, new research on wellness procedures using alternative medicines, expansion of consumer base and wellness industries, tourism is growing, that will incorporate wellness into travel, shift of consumers towards personal care products are some of the factors that will drive the medical wellness market. The awareness about medical wellness will help consumers, spread wellness to homes and their workplace and help the right way to exercise, include healthy eating in their diet, focus on preventive and personalized health and others. Lack of awareness about medical wellness, rise in products and services of wellness industry, lack of workforce and others are some of the factors restraining the market growth.

For Information On The Research Methodology request here @ https://www.persistencemarketresearch.com/methodology/18787

The global medical wellness market is segmented on basis of wellness sector, distribution channel and geography:

Segment by Wellness Sector

Segment by Distribution Channel

The global medical wellness market is segmented into wellness sector and distribution channel. Based on the wellness sector, the medical wellness market is segmented into complementary and alternative medicine, beauty care and anti-aging (surgical and non-surgical), preventative and personalized medicine, healthy eating, nutrition and weight loss, rejuvenation and others. The beauty care and anti- aging segment will dominate the wellness market due to rise in number of aesthetics procedures and increase in number of beauty care wellness sectors. Based on the end user, the medical wellness market is segmented as franchise and company owned outlets. The global medical wellness market is going to increase significantly is near future due to shift of consumers towards proactive approaches and include wellness in day to day life

To receive extensive list of important regions, Request TOC here @ https://www.persistencemarketresearch.com/toc/18787

By regional presence, the global medical wellness market is segmented into five broad regions viz. North America, Latin America, Europe, Asia-Pacific, and the Middle East & Africa. North America market is expected to dominate in terms of revenue share, owing to the high availability of advanced products and services, wellness tourism, expenditures growth, , increasing penetration of leading companies in the region along with increase in patient population. Significant economic development has led to an increase in healthcare availability in Asia Pacific region, growing number of multi-specialty care centers, rejuvenation and fitness centers and penetration of global players in Asia is expected to fuel the medical wellness market

Some of the major players in medical wellness market are Enrich Hair & Skin Solutions, VLCC Wellness Center, Guardian Lifecare, Healthkart, WTS International, The Body Holiday, Bon Vital, Biologique Recherch, MINDBODY Inc., Massage Envy, ClearCost Health, Golds Gym International, Inc., World Gym, Spafinder Wellness 365, Kaya Skin Clinic, Body master.

Explore Extensive Coverage of PMR`sLife Sciences & Transformational HealthLandscape

Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics andmarket research methodologyto help businesses achieve optimal performance.

To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.

Our client success stories feature a range of clients from Fortune 500 companies to fast-growing startups. PMRs collaborative environment is committed to building industry-specific solutions by transforming data from multiple streams into a strategic asset.

Contact us:

Tanvi BirajdarPersistence Market ResearchAddress 305 Broadway, 7th Floor New York City,NY 10007 United StatesU.S. Ph. +1-646-568-7751USA-Canada Toll-free +1 800-961-0353Sales[emailprotected]Websitehttps://www.persistencemarketresearch.com

See the original post here:

Demand for Medical Wellness Market to Witness Rapid Surge During the Period 2017 2025 - StartupNG

Alternative And Complementary Medicine Market Revolutionary Scope by 2 – News by aeresearch

The study of Alternative And Complementary Medicine market thoroughly analyzes the competitive landscape of this industry while focusing of market growth pattern over the past years and major global developments to predict the dynamics in the forthcoming years. The report is so drafted that companies operating in the business vertical can gain advantage from existing tends and construct strategies accordingly.

The document further highlights the growth opportunities and drivers stimulating the overall revenues of the market over the forecast period. Challenges and threats capable of dampening the industry growth are also enlisted in the report.

A comprehensive documentation of comparison between past and present market scenario is prepared to reckon the growth rate of the industry over the estimated timeframe. The report also encompasses details about the impact of COVID-19 on the business outlook and offers insights about potentials for industry players.

Request Sample Copy of this Report @ https://www.aeresearch.net/request-sample/294090

Key Takeaways from Alternative And Complementary Medicine Market Report:

Product Landscape:

Application Spectrum:

Regional Terrain:

Competitive Hierarchy:

In closing, the Alternative And Complementary Medicine market has been scrutinized extensively based on numerous parameters and segmentations, while elaborating on aspects like supply chain & sales channel, including downstream buyers and upstream raw material suppliers.

Market segmentation

The Alternative And Complementary Medicine market is split by Type and by Application. For the period 2020-2026, the growth among segments provides accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Research Objective:

Why to Select This Report:

Key questions answered in the report:

MAJOR TOC OF THE REPORT:

Chapter 1 Industry Overview

Chapter 2 Production Market Analysis

Chapter 3 Sales Market Analysis

Chapter 4 Consumption Market Analysis

Chapter 5 Production, Sales and Consumption Market Comparison Analysis

Chapter 6 Major Manufacturers Production and Sales Market Comparison Analysis

Chapter 7 Major Product Analysis

Chapter 8 Major Application Analysis

Chapter 9 Industry Chain Analysis

Chapter 10 Global and Regional Market Forecast

Chapter 11 Major Manufacturers Analysis

Chapter 12 New Project Investment Feasibility Analysis

Chapter 13 Conclusions

Chapter 14 Appendix

Request Customization on This Report @ https://www.aeresearch.net/request-for-customization/294090

Read more:

Alternative And Complementary Medicine Market Revolutionary Scope by 2 - News by aeresearch

A Cognitive-Behavioral Approach to the Treatment of Primary Dysmenorrhea – Physician’s Weekly

For a paper published in Pain Medicine, my colleagues and I developed a mind-body intervention, based on principles of cognitive-behavioral therapy (CBT), for young women with moderate-to-severe primary dysmenorrhea (PD; menstrual pain without an identified medical cause). As the most common gynecological complaint and leading cause of school and work absences in reproductive-age girls and women, menstrual pain is an important public health issue. First-line treatment approaches for PD include NSAIDs and hormonal contraceptives. However, these approaches have limitations. A recent study found as many as 18% of women with menstrual pain did not experience sufficient relief with NSAIDs. Additionally, NSAIDs and hormonal contraceptives come with the risk of significant side effects and may be intolerable for many. Because CBT is a widely used, evidence-based approach for treating chronic pain, we believe that patients with menstrual pain may benefit from learning similar skills. We utilized CBT principles in the development of a five-session, group treatment for menstrual pain.

The goals of this study were to determine whether the intervention was both feasible and acceptable to girls with menstrual pain and to evaluate the efficacy of the intervention on menstrual pain and other psychological variables. Feasibility was defined as at least 75% of participants attending at least three of five sessions, and acceptability was measured by a questionnaire administered at the end of the first session following an explanation of the rationale for the study. Efficacy was assessed by comparing pre-treatment self-reported menstrual pain ratings on a 0-10 scale to ratings made at post-treatment and follow-up. Additional self-report measures of somatization, depression, anxiety, and pain catastrophizing were also included at all assessments. All enrollees received the treatment in one of four group cohorts during the approximately 1-year study.

The group intervention was both feasible and acceptable to participants. Most importantly, participants reported significantly lower menstrual pain ratings at 3- and 12-month follow-up compared with pre-treatment, despite no changes in self-reported medication use. Only pain catastrophizing significantly improved over follow-up, while somatization, depression, and anxiety remained unchanged from pre-treatment. These findings suggest that a cognitive-behavioral approach to pain management is a viable and effective non-drug alternative to traditional pharmaceutical treatments for girls and women with menstrual pain. The improvement in pain catastrophizing suggests that this construct may be a potential mechanism of pain reduction. Because pain catastrophizing is often associated with chronic pain conditions and is a cognitive risk factor for future pain problems, teaching participants skills to modify catastrophic thoughts about pain may be a critical target of treatment.

Physicians, including pain specialists, should specifically ask patients about their experiences with menstrual pain to assess the degree to which it is problematic. It may be worth considering referring patients for CBT for menstrual pain (or even CBT for non-specific pain), particularly for those who do not tolerate or find sufficient relief from pharmaceutical approaches. Most importantly, it is crucial to have an open dialogue with patients about menstrual pain to help find effective treatment approaches and challenge the antiquated belief that girls and women just have to live with it.

While menstrual pain research is of great importance, there remains much to learn. Standard treatment approaches may work for the majority of girls and women, but a significant number will remain impaired and in pain. Future research should continue to evaluate non-drug treatments for PD in randomized controlled trials and improve the rigor and quality of trials testing alternative therapies (eg, acupuncture, herbs, supplements). Additionally, exploring mechanisms of symptom improvement may lead to a better understanding of the various factors contributing to girls and womens experiences of menstrual pain, so that personalized medicine approaches can be developed. When we are able to move away from a one size fits all approach, we will be able to reduce suffering and improve the lives of patients with this common and disabling pain condition.

An Open Trial of a MindBody Intervention for Young Women with Moderate to Severe Primary Dysmenorrheahttps://academic.oup.com/painmedicine/article-abstract/21/7/1385/5727725?redirectedFrom=fulltext.

Go here to read the rest:

A Cognitive-Behavioral Approach to the Treatment of Primary Dysmenorrhea - Physician's Weekly

New evidence testosterone therapy is effective obesity treatment in men – New Atlas

New data presented at the recent European and International Congress on Obesity suggests testosterone therapy may be a helpful treatment for some men suffering from obesity. The research finds long-term testosterone therapy can, in some cases, be as effective as bariatric surgery in morbidly obese subjects.

Low testosterone levels have consistently been detected in severely obese men, and obesity has also been noted as a common symptom of hypogonadism, a clinically diagnosed condition where men cannot produce average levels of testosterone. This complicated bidirectional relationship between obesity and low testosterone has been referred to as a vicious cycle by some researchers.

Farid Saad, from the UAEs Gulf Medical University School of Medicine, has been investigating the relationship between testosterone and obesity for over a decade. His latest research examines 15 years of data from a German registry tracking men with hypogonadism.

Saad and his colleagues looked at data from 471 obese men with hypogonadism, 276 of whom received long-term testosterone therapy, while 195 chose not to undergo hormone treatments, thus serving as a functional control group.

Across a follow-up period of about eight years, the data shows the testosterone group dropping 23 kg (50 lb) in weight, on average. The men in the control group not receiving testosterone therapy showed an average increase in weight of 6 kg (13 lb).

Waist circumference, body mass index, and visceral fat measurements all improved in the testosterone group compared to the control. Even more strikingly, the overall mortality rate of the testosterone group was significantly lower than the control by the end of the follow-up period: 7.6 percent vs 32.3 percent. Plus, over 20 percent of men in the control group developed type 2 diabetes across the study period, whereas no men in the testosterone group developed the metabolic disorder over the same timeframe.

"Long-term testosterone therapy in hypogonadal men resulted in profound and sustained weight loss which may have contributed to reductions in mortality and cardiovascular events, says Saad. Untreated men with hypogonadism gained weight."

Zooming in on those most obese subjects, the researchers found 76 men could be classified in the highest risk class 3 category of obesity. This category is occasionally referred to as morbid obesity, and bariatric surgery is often recommended as an effective treatment.

Of the 76 men in this category, 59 received testosterone therapy, and the remaining 17 served as controls. In this sub-group, the testosterone cohort lost an average of 30 kg (66 lb), while the control group gained an average of 5 kg (11 lb). Saad notes the weight loss and general metabolic improvements seen in this morbidly obese cohort following long-term testosterone therapy resemble benefits seen with bariatric surgery, suggesting this may be a useful alternative treatment option.

"Long-term testosterone therapy in men with hypogonadism and the most severe level of obesity resulted in profound and sustained weight loss in a magnitude comparable to that achieved with metabolic (obesity) surgery, says Saad. Side effects and complications may be in favor of testosterone therapy.

These results of course need broader validation before testosterone therapy can be widely recommended as a treatment for obesity in men. The data gathered in this new research is limited to a very specific cohort of older men with clinically diagnosed hypogonadism.

The new research was recently presented at the European and International Congress on Obesity.

Source: European Association for the Study of Obesity via Eurekalert

Excerpt from:

New evidence testosterone therapy is effective obesity treatment in men - New Atlas

Global Homeopathy Products Market Industry Analysis and Forecast (2019-2026) By Product, Application, Source, and Region. – Galus Australis

Global Homeopathy Products Marketwas valued US$4.85 Bn in 2018 and is expected to reach US$XX Bn by 2026, at a CAGR of XX % during a forecast period.

Global Homeopathy Products Market, by Region

Homeopathy is a field of alternative medicine. It works on the principle of similarity of symptoms, i.e., a substance causing symptoms of disease in a healthy individual will show the same symptoms in the sick. Homeopathic product involves treatment using natural sources such as plants, animals, and chemicals or minerals. It involves the administration of small doses of medicines with specific compositions. Homeopathy is known to be originated in Europe, brought up in the US, and progressed in India.

The increasing incidences of chronic and infectious diseases, improved research and development investment (R&D), and technological advancements are the key drivers which propelling market growth. On the other hand, the high cost of the components of the homeopathy medicines and the production constrains the growth of the market.

The increasing need for alternative treatment methodologies for chronic diseases is anticipated to drive the growth of the market during the forecast period. For example, according to the World Health Organization, homeopathic medicine is the fastest growing and second most widely used system of medicine in the world. Moreover, it is an economical treatment alternative. Homeopathic medicine is safe and effective, easy to use, and user-friendly for all age groups of patients, especially for the growing pediatric and geriatric population. On the other hand, negative opening and publicity against homeopathy medicine, false advertising, and misleading claims made by homeopaths are anticipated to hamper the market growth.

The report is majorly segmented into Product, Application, Source, and Region.

Product segment of Homeopathy Products Market is sub segmented into Product Tincture, Dilutions, Biochemics, Ointments, Tablets, and Others. Application segment is sub-segmented into Analgesic & Antipyretic, Respiratory, Neurology, Immunology, Gastroenterology, and Dermatology. Further, Source is sub segmented into Plants, Animals, and Minerals.

The region segment of Homeopathy Products Market is sub segmented into North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa.

Based on the product, the dilution segment held approximately XX% of the total homeopathy products market in 2018. The increase in demand for dilution medicines worldwide is expected to fuel this markets growth during the forecast period. The ointment segment is anticipated to show the XX% CAGR in the forecast period.

Based on the source the plants segment is expected to dominate the homeopathy product market, because of the amplified demand for natural medicines. The minerals segment is expected to show a rapid growth in the source segment.

On the basis of application, the increasing use of homeopathy for the treatment of various chronic diseases is expected to propel the growth of this market in the forecast period. The dermatology segment accounted for a XX% share in the global market in 2018 and is expected to register a XX% growth rate in future, due to increasing incidences of skin-related diseases globally.

North America is expected to account for the XX% share of the global homeopathy market during the forecast period due to the presence of a significant patient population, well-developed technology, high healthcare expenditure, and the presence of the leading players. The European market for homeopathy is anticipated to dominate the market during the forecast period. The vast patient population suffering from cancer and growing government support for research & development is anticipated to boost the growth of the market in this region.

Asia-Pacific is expected to be the fastest-growing market due to the growing need for better treatment methods, promptly improving technology, and the presence of a vast patient pool. In addition to this, emerging healthcare sector and growing government support has also fueled the market growth. The market in the Middle East & Africa is anticipated to witness steady growth due to the presence of slow but steady emerging countries.

The objective of the report is to present a comprehensive analysis of the Global Homeopathy Products Market including all the stakeholders of the industry. The past and current status of the industry with forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that includes market leaders, followers and new entrants. PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors in the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give a clear futuristic view of the industry to the decision-makers. The report also helps in understanding Global Homeopathy Products Market dynamics, structure by analyzing the market segments and project the Global Homeopathy Products Market size. Clear representation of competitive analysis of key players by End-User Industry, price, financial position, Product portfolio, growth strategies, and regional presence in the Global Homeopathy Products Market make the report investors guide.The scope of Global Homeopathy Products Market:

Global Homeopathy Products Market, by Product:

Tincture Dilutions Biochemics Ointments TabletsGlobal Homeopathy Products Market by Application:

Analgesic and Antipyretic Respiratory Neurology Immunology Gastroenterology DermatologyGlobal Homeopathy Products Market by Source:

Plants Animals MineralsGlobal Homeopathy Products Market, by Region:

North America Europe Middle East & Africa Asia Pacific Latin AmericaKey players operated in Global Homeopathy Products Market:

Boiron Group A Nelson & Co. Ltd. Standard Homeopathic Company Homeocan Inc. Medital International Inc. Biologische Heilmilttel Heel GmbH GMP Laboratories of America Inc. Washington Homeopathic Products, Inc. Hahnemann Laboratories, Inc. Ainsworths Ltd.

Global Homeopathy Products Market Request For View Sample Report Page : @https://www.maximizemarketresearch.com/request-sample/19024

About Us:

Maximize Market Research provides B2B and B2C market research on 20,000 high growth emerging technologies & opportunities in Chemical, Healthcare, Pharmaceuticals, Electronics & Communications, Internet of Things, Food and Beverages, Aerospace and Defense and other manufacturing sectors.

Contact info:Name: Vikas GodageOrganization: MAXIMIZE MARKET RESEARCH PVT. LTD.Email: [emailprotected]Website:www.maximizemarketresearch.com

Read the rest here:

Global Homeopathy Products Market Industry Analysis and Forecast (2019-2026) By Product, Application, Source, and Region. - Galus Australis

Alternative treatment for osteoarthritis | Alternative treatments – Medical News Bulletin

Osteoarthritis is the most common type of arthritis. Previously thought of as simple wear-and-tear type of arthritis, it is now recognized as a complex, progressive disease that affects the joints resulting in the breakdown of the joint cartilage and the underlying bone. Alternative treatments for osteoarthritis are being increasingly researched as strategies to manage this condition.

The hands and fingers, knees, hips, spine, and big toe are the most commonly affected joints. Symptoms of osteoarthritis include a limited range of motion, aching pain, weakness, stiffness, joint deformities, and morning stiffness lasting less than 30 minutes. Osteoarthritis pain progressively worsens in its later stages.

There are two types of osteoarthritis:

Since there is no cure for osteoarthritis, the main treatment goals are pain control and quality-of-life improvements. Management and treatment options are based on the severity of symptoms.

Non-drug therapies include, but are not limited to:

Drug therapies include, but are not limited to:

Research on Boswellia and its extracts have shown significant activity to combat inflammatory and arthritic diseases. Studies have shown that an active compound from Boswellia inhibits the inflammatory action caused by the enzyme, arachidonate 5-lipoxygenase. Clinical trials have reported that Boswellia and its extracts are relatively safe.

A review of seven studies investigated findings on the relief and improvement of pain, stiffness, and joint function using Boswellia as an alternative treatment for osteoarthritis. All seven studies utilized specific osteoarthritis pain rating scales and questionnaires to determine relief and improvement, such as the Visual Analog Score (VAS) and the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC).

The seven studies accounted for a total of 545 adults between 40 to 80 years old. All participants received either one of the following treatments for a duration of four or 12 weeks:

The review reported that Boswellia and its extracts may improve pain, stiffness, and joint function compared to placebo or western medicine, making it a promising alternative treatment for osteoarthritis. Unfortunately, the review discovered that all seven studies had either unclear (86%) or high (57%) risk of bias. The risk of bias means that the study variations make it difficult for researchers to make consistent and solid conclusions. The unclear and high risk of bias stemmed from poor reporting of study procedures, such as randomization, allocation concealment, participant/researcher blinding, selective reporting and incorrect calculation of statistics.

Although Boswellia and its extracts seem safe, the safety data remains unclear with no reported side effects in Boswellia nor placebo treatment, from three out of seven studies. According to the authors, The absence of information on adverse events does not mean that the intervention [Boswellia] is safe.

This was the first study to provide a recommended dosage and duration of Boswellia and its extract, with 100 to 250 mg daily for four weeks. Boswellias safety and effectiveness as an alternative treatment for osteoarthritis requires further studies with larger population sizes, standardized dosing preparations, dosage outside of 100-250mg, and longer treatment durations.

Written by Manuel Bangsil, PharmD, MBA, BCMAS

References:

Image byxbqs42fromPixabay

Link:

Alternative treatment for osteoarthritis | Alternative treatments - Medical News Bulletin

Djokovic has a Federer moment at the US Open – Moneycontrol.com

Life has come full circle for Novak Djokovic. By getting defaulted from the US Open, the World No. 1 lost a title that was his for the taking. Just like Roger Federer at Wimbledon 2019, when Federer squandered two match points against, well, Djokovic.

At that time, people said of Federer, How could he? How could such a great player, a mere one stroke from victory, on his own serve, let it slip? Many of them were Djokovic fans. They mocked Federer as they savoured their mans lucky escape.

And now, just about a year later, the same question is being asked of Djokovic. How could he? How could such an experienced player do something so stupid, if not intentional, as smack a ball in disgust towards a linesperson, despite being aware of the rules and risks? How could an otherwise charming player, who invites ballkids to sit with him during rain breaks, do something so careless?

We are not nave. We know people have contradictions and mistakes happen. But the thing is, Djokovics costly swipe at the ball wasnt his first demonstration of anger in the match. Moments earlier, he had slammed one hard in the sideboards. At that moment, he could have warned himself. Calm down, if someone gets hit, you could be kicked out of the tournament. Curse, scream, break your racquet. But dont do anything where the racquet or ball hit another person. The rules are clear about that.

And now Djokovic, his team and admirers are feeling what the Federer camp felt after last years Wimbledon the agony of losing a major title when it was almost a done deal.

Facepalm season

Its been a season of blunders and stress for Djokovic. First, he expressed opposition to the idea of mandatory COVID vaccination by the tennis body, which was seen as insensitive in some quarters. Then in June, he organised an ill-advised exhibition tournament named Adria Tour in Croatia. Spectators packed the stands. Players hugged and danced at a party and played basketball with no distancing. Djokovics intentions were noble. He wanted to do something good for players and the public during the bleak days of the coronavirus. But it proved to be a disaster. Several people, including Djokovic and his wife Jelena, tested positive for the virus. Djokovic was widely criticized and spent precious time and energy explaining his actions and apologizing.

But then he took the brave call of travelling to the US for the US Open, never hiding his motivation to dislodge Federer from the tennis peak (Federer has 20 Grand Slams, Nadal 19 and Djokovic 17). When Djokovic won the Cincinnati Masters in the run-up to the US Open, the Adria Tour fiasco seemed behind him and he seemed on course for Major No. 18.

Djokovic, however, once again made a surprising decision to announce, right in the middle of a major tournament, that he was forming a new players association. Top players do not usually take on tiring parallel responsibilities during big tournaments, let alone talk about them. Unlike the Adria Tour, there was nothing objectionable about the players association. But Djokovic had to answer questions about it during press conferences, at a time when he needed to focus solely on the US Open. Finally came the moment of madness on Sunday when his absently slapped ball, to his absolute horror, hit a lineswoman.

Most temperamental of the Big 3, also the funniest

There is little to separate Federer, Nadal and Djokovic in terms of achievements. But Djokovic can be the most entertaining as well as the most temperamental of the elite trio. His impersonations of players and practical jokes are hilarious. At the same time, despite his greatness and success, his calm seems brittle. Things get to him more than they do to Federer or Nadal, and the hitherto invulnerable game starts to unravel. At the US Open, he was at times bellowing in anger even when he was winning.

Djokovics training, regimen and diet are painstakingly drawn from modern science as well as alternative medicine. Among other things, he believes a persons emotions can change the molecular structure of the water he or she drinks. Djokovic also famously turned his career around by going gluten-free. At last years US Open, he carried an oxygen chamber to the grounds.

See the article here:

Djokovic has a Federer moment at the US Open - Moneycontrol.com

COVID-19 Impact on Medical Wellness Market Surge at 5.4% CAGR to 2025 – Galus Australis

Global Medical Wellness Market Growth Status and Outlook 2020-2025

Wellness describes itself as complete physical mental and social well-being. It comprises all the components used to lead a healthy life. Wellness is multidirectional and constitutes social, emotional, physical, spiritual, intellectual and emotional wellbeing.

According to this study, over the next five years the Medical Wellness market will register a 5.4% CAGR in terms of revenue, the global market size will reach $ 6107270 million by 2025, from $ 4949690 million in 2019. In particular, this report presents the global revenue market share of key companies in Medical Wellness business, shared in Chapter 3.

This report presents a comprehensive overview, market shares and growth opportunities of Medical Wellness market by type, application, key companies and key regions.

Get Sample Copy Of this report: https://bit.ly/355F6c4

Companies Profiled in this report includes: Massage Envy, HEALING HOTELS OF THE WORLD, Steiner Leisure Limited, Fitness World, Universal Companies, World Gym, Nanjing Zhaohui, Beauty Farm, Edge Systems LLC, VLCC Wellness Center, Arashiyu Japanese Foot Spa, WTS International, Enrich Hair & Skin, Golds Gym International, The Body Holiday, Kaya Skin Clinic, Guardian Lifecare, Kayco Vivid, Bon Vital, Biologique Recherche, Healthkart

This study considers the Medical Wellness value generated from the sales of the following segments:

Segmentation by type: breakdown data from 2015 to 2020 in Section 2.3; and forecast to 2025 in section 10.7.

Complementary and Alternative Medicine

Beauty Care and Anti-Aging

Preventative & Personalized Medicine and Public Health

Healthy Eating, Nutrition & Weight Loss

Rejuvenation

Other

Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2025 in section 10.8.

Franchise

Company Owned Outlets

Get Discount of this report: https://bit.ly/357qr02

Research objectives

To study and analyze the global Medical Wellness market size by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.

To understand the structure of Medical Wellness market by identifying its various subsegments.

Focuses on the key global Medical Wellness players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.

To analyze the Medical Wellness with respect to individual growth trends, future prospects, and their contribution to the total market.

To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

To project the size of Medical Wellness submarkets, with respect to key regions (along with their respective key countries).

To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.

To strategically profile the key players and comprehensively analyze their growth strategies.

Table of Content:

1 Scope of the Report

2 Executive Summary

3 Global Medical Wellness by Players

4 Medical Wellness by Regions

5 Americas

6 APAC

7 Europe

8 Middle East & Africa

9 Market Drivers, Challenges and Trends

10 Global Medical Wellness Market Forecast

11 Key Players Analysis

11.1 Massage Envy

11.1.1 Company Details

11.1.2 Medical Wellness Product Offered

11.1.3 Massage Envy Medical Wellness Revenue, Gross Margin and Market Share (2018-2020)

11.1.4 Main Business Overview

11.1.5 Massage Envy News

11.2 HEALING HOTELS OF THE WORLD

11.2.1 Company Details

11.2.2 Medical Wellness Product Offered

11.2.3 HEALING HOTELS OF THE WORLD Medical Wellness Revenue, Gross Margin and Market Share (2018-2020)

11.2.4 Main Business Overview

11.2.5 HEALING HOTELS OF THE WORLD News

11.3 Steiner Leisure Limited

11.3.1 Company Details

11.3.2 Medical Wellness Product Offered

11.3.3 Steiner Leisure Limited Medical Wellness Revenue, Gross Margin and Market Share (2018-2020)

11.3.4 Main Business Overview

11.3.5 Steiner Leisure Limited News

11.4 Fitness World

Complete Report: https://bit.ly/355FhUM

Contact Info:Name: Sameer JoshiEmail:[emailprotected]Company Name: ReportsWebWebsite: Reportsweb.com

Phone: +1-646-491-9876

About ReportsWeb:

ReportsWeb.com is a one stop shop of Market research reports and solutions to various companies across the globe. We help our clients in their decision support system by helping them choose most relevant and cost effective research reports and solutions from various publishers. We provide best in class customer service and our customer support team is always available to help you on your research queries.

Request for Customization:

Any special requirements about this report, please let us know and we can provide custom report.

See original here:

COVID-19 Impact on Medical Wellness Market Surge at 5.4% CAGR to 2025 - Galus Australis

Coronavirus live updates: Pfizer says vaccine may be ready by end of October; infected Big Ten athletes have heart inflammation – USA TODAY

COVID-19 widespread testing is crucial to fighting the pandemic, but is there enough testing? The answer is in the positivity rates. USA TODAY

Amid reports that the Centers for Disease Control and Prevention is telling some health officials around the country to be ready to start distributing a coronavirus vaccine by November, the chairman and CEO of Pfizer said Thursday that the company may have an effective vaccine by the end of October.

That timeline is "conceivable" but not likely,Dr. Anthony Fauci, the nation's top infectious disease expert, told CNN Thursday.

Meanwhile, higher education continuesto grapple with the impact of the ongoing coronavirus pandemic.

The Penn State University director of athletic medicine raised alarms when he reported that about one-third of Big Ten athletes who tested positive for the coronavirus also appear to have inflammation of the heart muscle, or myocarditis, a potentially fatal condition.

In addition, nearly 800 students at the University of Georgia tested positive for COVID-19 or reported positive tests last week, the first full week of classes, and the university has set aside or rented nearly 500 rooms on and off campus for students in quarantine or isolation.Iowa State University onWednesday reversed its decision to allow 25,000 fans to its home-opening footballgame, and 30 out of 40 Greek houses at Indiana University-Bloomington were asked to quarantine after a spike in cases.

Some universities, however, are staying the course. University of South Carolina officials said they hadno plans of shutting down campus even after reporting more than 1,000 confirmed cases among students.

Some significant developments:

Today's numbers:A USA TODAY analysis of Johns Hopkins data through late Wednesday shows three statesMinnesota, South Dakota and West Virginiaset records for new cases in a week while two statesArkansas and West Virginiahad a record number of deaths in a week. The U.S. has 6.1 million confirmed cases and over 186,000 deaths. Globally, there are 26million cases and more than 864,000 people have died.

What we're reading:Operation Quack Hack, the federal governments initiative to clamp down on fake coronavirus medications and cures, has exposed a health underground in America brimming with distrust not only of mainstream medicine but the government itself. Read more here.

This file will be updated throughout the day. For updates in your inbox,subscribe to theDaily Briefing.

The possible link between COVID-19 and a potentially fatal inflammation of the heart muscle detected on Big Ten athletes seems to validate the conference's decision to postpone fall sports amid the pandemic, at the same timeraising questions about the safety of student-athletes in other leagues that are choosing to play.

Major concerns were raised when Dr. Wayne Sebastianelli, Penn State'sdirector of athletic medicine, made the revelation at a meeting of the State College Area school board of directors, saying that information contributed to the Big Ten and Pac-12 postponing the fall seasons. The other Power Five conferences -- the SEC, ACC and Big 12 -- have decided to play.

When we looked at our COVID-positive athletes, whether they were symptomatic or not, 30 to roughly 35 percent of their heart muscles [are] inflamed, Sebastianelli said. And we really just dont know what to do with it right now.''

Dr. Robert Glatter, an emergency physician and former sideline doctor for the New York Jets, says it may be time to put all fall sports on hold, pointing out the danger myocarditis presents.

"We need to reconsider allowing all professional, collegiate as well as school sports at all levels from going forward this fall,'' Glatter said. "I believe we need to wait until a viable vaccine is available beforewe can safely allow organized sports at all levels of competition to proceed.''

The chairman and CEO of Pfizer said Thursday the company may have an effective coronavirus vaccine by the end of October.

"We may be able to say the product is safe and efficacious in the October time frame and submit immediately for approval and authorization,"Dr. Albert Bourla told the International Federation of Pharmaceutical Manufacturers and Associations in a virtual meeting.

Bourla said the U.S.-based company, which is developing its vaccine in partnership with German biotechnology company BioNTech, has enrolled 23,000 participants in its Phase 3 clinical trial and aims to enroll 30,000 total. A "significant number"of participants have already started getting the second dose of the experimental vaccine, Bourla said.

The Centers for Disease Control and Prevention, meanwhile, has told some state health officials to prepare to distribute the vaccine "in the near future."

Providers of alternative medicines and treatment are mobilizing against the federal government in its attempt to stamp out fake cures against the coronavirus.They are angry about government warning letters that they believe infringe on their right to free speech, free trade and people's control over their health care. And they've got a strong argument in fighting back: How can we trust the same government that signed off on opioids?

The backlash follows Operation Quack Hack, the federal governments initiative to clamp down on fake coronavirus medications and cures.

The health care system in this country is rigged against inexpensive, safeand effective natural remedies in favor of expensive pharmaceutical drugs, said Clark Hansen, a naturopathic medical doctor in Arizona, in an email message to USA TODAY.

Michael Braga

Latinos, Blacks and recent immigrants, who fill eight out of 10 of the nation's front-line meatpacking jobs, now account for 90% of the meatpacking-related coronavirus cases, based on an analysis by the Centers for Disease Control and Prevention.

A two-month project by the Midwest Center for Investigative Reporting and USA TODAY looking at data from 21 states foundthe government has taken an even more hands-off approach to employee safety even as workers' and activists' calls forbasic safety measures were met with months of inaction and indifference.

Heather Schlitz, Midwest Center for Investigative Reporting

Speeding and traffic fatalities are both up in Vermont, and law enforcement officials think they know the reason: fewer cops to enforce traffic laws because of the coronavirus.

The state has seen 43 traffic deaths so far this year, up from 21 at the same point last year. And125 lead-footed motorists were cited for speeding faster than 99 miles per hour through Sept. 1, up from 107 during the same period last year, reports the Barre Montpelier Times Argus.

Though there appears to be no single reason for the increase, the coronavirus could be a factor for having thinned the number of law enforcement officers on the highways

When you drive around, people seem to be speeding more. They seem to be looking at their phones more. They do not see law enforcement out as much as they used to, Bill Jenkins of the state Highway Safety Office said. I think some people, unfortunately, got the message that they could do things that they shouldnt be doing.

Dr. Theresa Tam, Canada's Chief Public Health Officer, is warning Canadians to practice safe behaviors with their sex lives amid the pandemic.

"Sexual health is an important part of our overall health. However, sex can be complicated in the time of COVID-19, especially for those without an intimate partner in their household or whose sexual partner is at higher risk for COVID-19,"Tam said in a statement.

Among the measures that Tam suggested Canadians take to avoid their risk: Wearing a mask if they do have sex andavoiding kissing. "The most important step is to establish a trusting relationship with your sexual partner," Tam added.

More than 833,000 Americans sought unemployment assistance last week as parts of the economy remained shuttered because ofCOVID-19 and millions of out-of-work people have gone more than a month without the additional $600 in jobless aid.

About 833,352 Americans filed first-time applications for unemployment insurance during the week ending Aug. 29, the Labor Department said Thursday, a 7,591 rise from the prior week and slightly more than the 825,000 expected by economists at J.P. Morgan.Those figures are based on non-seasonally adjusted figures.

Jessica Menton

The Dow fell more than 800 points Thursday, offsetting big gains the previous day.It was the worst day for stocks since June.

Stocks on Wednesday soared, with the S&P 500 the broadest measure of Wall Street and the Nasdaq hitting highs.The Nasdaq had also climbed above 12,000 points for the first time in history Wednesday.

Experts said the sudden downturn came amid a steep drop in tech companies' stocks brought the rest of the market lower.

Filming on the movie "The Batman" starring Robert Pattinson was stoppedafter a member of the U.K. production team tested positive for COVID-19.

The shoot at Warner Bros. studio in Hertfordshire, England, came to a halt after resuming production three days ago. It is being directed by Matt Reeves.Production of "The Batman" was originally shut down in March by the coronavirus crisis.

Bryan Alexander

Florida's largest school district has been plagued with outages and cyberattacks as it reopens virtually amid the pandemic.

Students and teachers in recent days have both said they can't access the online platform used by Miami-Dade County schools, the Miami Herald reported. Moreover, Ron Steiger, thedistricts chief financial officer, said Wednesday thata $15.3 million contract with the online platform at the center of the crisis was missing the signature of Superintendent Alberto Carvalho.

District officials have determined the cyberattackers have demanded no ransom, and some of the attacks came from outside the U.S.

On Wednesday night, an email was sent to all secondary school teachers asking them to use Microsoft Teams and Zoom until Sept. 11. The district will then assess if grades six through 12 will use the platform beginning Sept. 14 or stick with Microsoft Teams and Zoom.

A new study suggests the COVID-19 pandemic has generated fears that are likely to dampen risk-taking and economic output for decades.

The crisis has increasedthe perceived probability of an extreme, negative shock in the future, and over time, the economic cost of that warier outlook is many times larger than the short-term damage, the study says.

The study,released at the Federal Reserve Bank of Kansas Citys annual conference last week,attempts to quantify such long-term economic losses by assessing the toll taken by other economic upheavals, such as the Great Recession of 2007-09.

Paul Davidson

More than 1,000 students at the University of South Carolina have tested positive for COVID-19, according to the university's dashboard. ButPresidentRobert Caslen on Wednesday said he has no plans of shutting down the school, The State newspaper reported.

We do not have any plans to close, Caslen said during a virtual town hall. The last thing I want to do is take this university, shut it down and dump the problem on the city of Columbia. I prefer to work through this if I can.

One way school officials plan to do so is by testing more students. "We want to find them, we want to take care of them and we want to get them back into the classroom," he said.

Also in South Carolina, Furman University suspended theKappa Alpha fraternity for at least four years after it hosted parties that helped spread the virus. Nearly 60% of those who attended the events on Aug. 21 and 22 at least 29 students tested positive for the coronavirus.

Meanwhile, other universities are pausing their in-person reopening plans ascases spike on their campuses. Here is the latest:

Autoplay

Show Thumbnails

Show Captions

Its more and more likely the nation wont have enough teachers to staff schools even once reopening is safe amid the public health and economic crises caused by the pandemic, experts say.

A potential exodus of older educators susceptible to the coronavirus and those with existing health problems may fuel already high turnover.

Many substitutes also may quit. Now, new restrictions on foreign visas will make it harder for some states to import teachers from other countries to work in already hard-to-staff positions.

And for those teachers willing to return to the classroom whether virtually or in person pink slips may be coming later this year asstate tax revenue isdecimated and budgets slashed.

Bracey Harris and Neal Morton, The Hechinger Report

On Facebook:There's still a lot unknown about the coronavirus. But what we do know, we're sharing with you.Join our Facebook group,Coronavirus Watch,to receive daily updates in your feed and chat with others in the community about COVID-19.

In your inbox:Stay up-to-date with the latest news on the coronavirus pandemic from the USA TODAY Network.Sign up for thedailyCoronavirus Watchnewsletter.

Tips for coping:Every Saturday and Tuesday we'll be in your inbox, offering you a virtual hug and a little bit of solace in these difficult times.Sign up forStaying Apart, Together.

Contributing: The Associated Press

Autoplay

Show Thumbnails

Show Captions

Read or Share this story: https://www.usatoday.com/story/news/health/2020/09/03/covid-19-news-dwayne-johnson-cdc-vaccine-united-airlines-sturgis/5700013002/

View post:

Coronavirus live updates: Pfizer says vaccine may be ready by end of October; infected Big Ten athletes have heart inflammation - USA TODAY

$700 Million Worth of Synthetic Bitcoin Is Circulating on the Ethereum Blockchain – Bitcoin News

According to onchain data, theres now 69,836 synthetic bitcoin tokens (over $700 million) circulating on the Ethereum blockchain. Out of the six synthetic bitcoin token projects, wrapped bitcoin (WBTC) commands the largest number of coins with over 63% and 44,622 WBTC.

Synthetic bitcoin (BTC) has grown massively in recent weeks and since news.Bitcoin.coms last report on the subject, there was 38,021 BTC circulating on the Ethereum chain.

Since then, that metric has jumped more than 83% as theres now 69,836 synthetic bitcoin tokens in the wild on September 7, 2020. Dune Analytics shows there are seven synthetic BTC projects but tBTC has zero coins minted, while the other six projects have between 45 BTC to over 40,000.

The top project minting the most synthetic BTC is the Wrapped Bitcoin (WBTC) protocol which commands roughly 44,622 BTC to-date or 63%. The Ren Protocols renBTC has over 23% of the aggregate total of synthetic BTC with 16,268 renBTC in circulation today.

The token hBTC has 4,810 and sBTC has a total of 2,918 at the time of publication. The two projects with the least amount of synthetic BTC is imBTC (1,173) and pBTC (45).

WBTC has gained a lot of traction, and on Monday reports detail that the organization Alameda Research obtained 70% of the WBTC minted in August. Alameda was cofounded by the FTX CEO Sam Bankman-Fried.

A great percentage of synthetic bitcoin is circulating among holders while the rest is used on platforms such as Compound, Balancer, Aave, and Uniswap.

Synthetic bitcoin trades take place on a few centralized exchanges like FTX and Binance has revealed listing WBTC this week. On decentralized exchange (dex) platforms, Synthetic bitcoin trades are happening on 0x, Bancor, Synthetix, Balance, Curve, and Uniswap.

Despite the massive growth and popularity, Ethereum cofounder Vitalik Buterin detailed that he has concerns about synthetic bitcoin projects.

I continue to be worried about the fact that these wrapped BTC bridges are trusted, Buterin wrote on August 16. I hope they can all *at least* move to a decently sized multi-sig, the developer added.

Following Buterins statements, the community discussed a research paper by the Wanchain project which claimed the Ren Protocol kept all the collateralized bitcoin in one address.

Paradoxically, we found that the Bitcoin address provided by renBTC that users transfer their real BTC to for locking has not changed since the first day it went online, the Wanchain report wrote.

Despite the trust issues, with 69,836 synthetic bitcoin tokens on the Ethereum blockchain, the ETH network continues to solidify itself as BTCs most dominant offchain solution.

What do you think about the $700 million worth of BTC circulating on the ETH chain in synthetic form? Let us know in the comments below.

Image Credits: Shutterstock, Pixabay, Wiki Commons, Dune Analytics,

Disclaimer: This article is for informational purposes only. It is not a direct offer or solicitation of an offer to buy or sell, or a recommendation or endorsement of any products, services, or companies. Bitcoin.com does not provide investment, tax, legal, or accounting advice. Neither the company nor the author is responsible, directly or indirectly, for any damage or loss caused or alleged to be caused by or in connection with the use of or reliance on any content, goods or services mentioned in this article.

Read the original here:

$700 Million Worth of Synthetic Bitcoin Is Circulating on the Ethereum Blockchain - Bitcoin News

Exclusive mining could have negative implications for the Blockchain industry, say experts – Cointelegraph

Dr. Elias Strehle of the Blockchain Research Lab and Lennar Ante of the University of Hamburg recently warned that blockchain nodes engaging in exclusive mining have no incentive to forward new transactions to their peers.

They speculated that crypto miners may instead be incentivized to keep transactions confidential in the hope of being the only one who can earn the associated transaction fees.

Exclusive mining, which is a type of collusion between a transaction initiator and a single miner or pool, uses private channels to confirm transactions rather than broadcasting them on the public blockchain. It is only after they are recorded in a block that public blockchain that users become aware of such transactions.

The authors alleged that, since transaction costs represent regular income for miners, significantly increased transaction costs could be used to launder money by colluding with a miner.

As a result, criminals may see smaller blockchain networks as more suitable vehicles for money laundering or tax evasion via exclusive mining, the researchers noted.

Dr. Strehle and Ante identified two other possible motivations for engaging in exclusive mining: reducing transaction cost volatility and hiding unconfirmed transactions from the network to prevent frontrunning.

In June, Cointelegraph reported on a number of mysterious transactions that have stumped the wider community. Some suggest they could be examples of money laundering, or revenge from a disgruntled exchange employee.

Read more from the original source:

Exclusive mining could have negative implications for the Blockchain industry, say experts - Cointelegraph

Reimagining blockchain for healthcare solutions with the MAXathon – Health Europa

Blockchain technology company Maxonrow is hosting its first ever hackathon to help reimagine blockchain for applications in healthcare in response to the global challenges posed by the COVID-19 pandemic.

The MAXathon challenges are based on the Maxonrow SDK script, which the company used to build MedsLOCK. Created in tandem with Avantas Tech Accelerator, MedsLOCK is a blockchain-based control and communication ecosystem that provides real-time insights during pandemics.

During the COVID-19 outbreak, data is crucial to making informed decisions. At the same time, citizens are concerned about any incursion to privacy resulting from data collection initiatives.The MedsLOCK platform provides a single source of reliable, verifiable pandemic analytics to government agencies, health officials, and other stakeholders, and the core objective is to make COVID-19 data collection and exchange between stakeholders automated, transparent, and trusted with the help of distributed ledger technology.

Muhammad Salman Anjum, Avantas Managing Director, said: Privacy is a key issue during the current and future pandemics, and as such, blockchain platforms ensure that information is shared without compromising privacy. With MedsLOCK, we make sure we add trust to the data flow.

Participants in the MAXathon hackathon will have a chance to win a share of a 15,000 prize pool by building solutions for any of the five challenge categories.

The challenges categories are:

Physical Distancing Distancing measures are one of the most impactful ways to contain the spread of COVID-19. How can we use analytics in smarter solutions to help governments implement social or physical distancing measures?

Credential and Certificate Issuance Governments need a way of easily verifying if a patient has had COVID-19 and is virus-free. Help us build a solution that can help governments quickly retrieve verifiable data.

Welfare Businesses and citizens have become reliant on governments for welfare due to the restrictions imposed by the pandemic. Can we lower transaction costs by removing intermediaries and increasing transparency to welfare beneficiaries?

Virtualising the New Normal Are there any creative ways that blockchain can be used to navigate the need for physical distancing, creating new virtual paths to connect with one another?

UI/UX There are many data representations of the pandemic. How can we present a holistic, multi-dimensional dashboard with unique features?

Maxonrow has assembled a stellar team of judges and mentors for MAXathon, including Holger Schmidt, partner at PwCs strategy division, Nisa Amoils of VC firm Grasshopper Capital, along with representatives from Audi, Dash.org, and members of Maxonrow and Avantas Techs senior leadership.

There will also be 16 mentors working with participating teams, comprised of members of Maxonrows technical teams and leaders within the blockchain space.

The latter includes Amber Urquhart, Head of Business Development at quant trading firm TDX Strategies, Gabriel Dymowski, CEO at Doxychain, and a laureate of Forbes 25 under 25. Also participating in the mentorship team are Massimo Buoni, a UN global technology expert, and Steven Boylan, co-founder and CEO of Trt:Labs, a specialist digital transformation consultancy.

More:

Reimagining blockchain for healthcare solutions with the MAXathon - Health Europa

All fintech companies will use blockchain within 10 years: Aussie government report – Cointelegraph

The Australian governments Senate Select Committee on Financial Technology and Regulatory Technology has released a draft report citing blockchain technology more than 50 times.

The report is in response to Australias first recession in 30 years as a result of COVID-19, which was confirmed in the June quarters negative growth announced on September 2.

The document makes numerous recommendations about how the nation can embrace technology and become globally competitive said committee head Senator Andrew Bragg. He added:

There are dozens of references to blockchain and distributed ledger technology and the report cites submissions to the committee that blockchain's potential is estimated at $175 billion annually within five years and $3 trillion by 2030. It quoted Piper Alderman partner Michael Bacina as saying blockchains use cases would grow exponentially across the financial and regulatory sectors:

The tax treatment of Initial Coin Offerings (ICOs) was addressed specifically with the recommendation that the regulatory framework around ICOs be developed to encourage blockchain development rather than inhibit it.

Power Ledgers co-founder and Executive Chairman Dr Jemma Green highlighted that more than $26 billion had been raised through ICOs, however Australia has captured less than one percent of this value. She explained that by implementing new tax regulations the country could capitalise on the opportunity, to capture a bigger piece of that $26 billion pie which would result in employment for employ tens of thousands of people.

Other use-cases for the technology cited include blockchain as a reporting and management tool for property data and investments, and within the credentialing sector.

The technology will also play an integral part in Australia's farming success through agricultural advancements, a sector set to grow to $100 billion by 2030 according to the National Farmers Federation. Senator Bragg said innovative technology is the only future for the farming sector.

The Committee will submit the final report in April 2021.

See more here:

All fintech companies will use blockchain within 10 years: Aussie government report - Cointelegraph

‘Decentralized Reddit’ enables users to secure Twitter on the blockchain – Cointelegraph

Reddit-inspired social aggregation platform Discussions.app announced its expansion to the Telos network on Sept. 3.

The first project to come out of the new collaboration will be a decentralized identity system, allowing users to record their accounts and contacts from Twitter and other social networks to the blockchain in the event of a block or ban.

In the social-media age, users spend years growing networks and followers on various platforms, although this work can be destroyed by the sometimes arbitrary-seeming decisions of the networks.

Discussions.app addresses this by allowing users to migrate across platforms without losing their valuable identities and connections. Telos chief architect Douglas Horn explained the problem:

It seems that every few days I see another unique voice de-platformed and the connections they invested years building pulled out from under them like a cheap rug especially in the crypto community. Discussions.app empowers individuals to secure their own social networks immune to the whims of Facebook, YouTube and Twitter.

As Cointelegraph reported, YouTube has arbitrarily banned (and then reinstated) a number of crypto-related channels over the past few months. In May, the platform even pulled the plug on our special livestream of the halving event.

In addition to digital identity management, Telos will provide Discussions.app with options for advanced governance and Ethereum Virtual Machines which can run Ethereum-compatible smart contracts with zero transaction fees.

Go here to read the rest:

'Decentralized Reddit' enables users to secure Twitter on the blockchain - Cointelegraph